BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kostakoglu L, Fardanesh R, Posner M, Som P, Rao S, Park E, Doucette J, Stein EG, Gupta V, Misiukiewicz K, Genden E. Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck. Oncologist 2013;18:1108-17. [PMID: 24037978 DOI: 10.1634/theoncologist.2013-0068] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Abdel Razek AAK. Diffusion tensor imaging in differentiation of residual head and neck squamous cell carcinoma from post-radiation changes. Magnetic Resonance Imaging 2018;54:84-9. [DOI: 10.1016/j.mri.2018.08.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
2 Suenaga Y, Kitajima K, Ishihara T, Sasaki R, Otsuki N, Nibu K, Minamikawa T, Kiyota N, Sugimura K. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT. Eur Radiol 2016;26:1018-30. [PMID: 26188656 DOI: 10.1007/s00330-015-3902-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
3 Imbimbo M, Alfieri S, Botta L, Bergamini C, Gloghini A, Calareso G, Orlandi E, Iacovelli NA, Guzzo M, Granata R, Resteghini C, Locati L, Volpi CC, Licitra L, Bossi P. Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up. Otolaryngol Head Neck Surg 2019;161:635-42. [PMID: 31286827 DOI: 10.1177/0194599819860808] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
4 Zabrodsky M, Lukes P, Lukesova E, Boucek J, Plzak J. The role of narrow band imaging in the detection of recurrent laryngeal and hypopharyngeal cancer after curative radiotherapy. Biomed Res Int 2014;2014:175398. [PMID: 25101264 DOI: 10.1155/2014/175398] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
5 Rohren EM, Dillehay GL, Jadvar H. SNMMI Comment on ASCO 2013 “Choosing Wisely” Recommendation on Use of PET/CT in Recurrent Cancer Surveillance. J Nucl Med 2014;55:699-700. [DOI: 10.2967/jnumed.114.139683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Kim S, Roh J, Kim JS, Lee JH, Lee SH, Choi S, Nam SY, Kim SY. 18F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer. European Journal of Cancer 2017;72:62-70. [DOI: 10.1016/j.ejca.2016.11.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
7 Sagardoy T, Fernandez P, Ghafouri A, Digue L, Haaser T, de Clermont-Galleran H, Castetbon V, de Monès E. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up. Head Neck 2016;38 Suppl 1:E1271-6. [PMID: 26315809 DOI: 10.1002/hed.24204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
8 Wray R, Sheikhbahaei S, Marcus C, Zan E, Ferraro R, Rahmim A, Subramaniam RM. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features. AJR Am J Roentgenol 2016;207:641-7. [PMID: 27341273 DOI: 10.2214/AJR.15.15730] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Roman BR, Lohia S, Mitra N, Wang MB, Pou AM, Holsinger FC, Myssiorek D, Goldenberg D, Asch DA, Shea JA. Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancer. Head Neck 2020;42:974-87. [PMID: 31919944 DOI: 10.1002/hed.26071] [Reference Citation Analysis]
10 Abdel Razek AAK, Gaballa G, Ashamalla G, Alashry MS, Nada N. Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Recurrent Head and Neck Cancer From Postradiation Changes: . Journal of Computer Assisted Tomography 2015;39:849-54. [DOI: 10.1097/rct.0000000000000311] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 4.4] [Reference Citation Analysis]
11 Varghese BT, Patil S. Completion Total Laryngectomy Ten Years After Near Total Laryngectomy for Radiorecurrent Cancer of the Glottis. Indian J Surg Oncol 2018;9:605-8. [PMID: 30538399 DOI: 10.1007/s13193-018-0795-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Kikuchi M, Shinohara S, Hino M, Itoh K, Tona R, Kishimoto I, Harada H, Fujiwara K, Suehiro A, Naito Y. Detection of subclinical recurrence or second primary cancer using 18 F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma: Surveillance using 18 F-FDG PET/CT. Head Neck 2016;38:E511-8. [DOI: 10.1002/hed.24032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
13 Cammaroto G, Quartuccio N, Sindoni A, Di Mauro F, Caobelli F; Young AIMN Working Group. The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature. Eur Arch Otorhinolaryngol 2016;273:1961-73. [DOI: 10.1007/s00405-015-3651-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kim ES, Yoon DY, Moon JY, Baek S, Han YM, Seo YL, Yun EJ. Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT. Acta Radiol 2019;60:186-95. [PMID: 29754496 DOI: 10.1177/0284185118776504] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
15 Workman AD, Palmer JN, Adappa ND. Posttreatment surveillance for sinonasal malignancy. Curr Opin Otolaryngol Head Neck Surg 2017;25:86-92. [PMID: 27846019 DOI: 10.1097/MOO.0000000000000330] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
16 You H, Subramaniam RM. PET/Computed Tomography. PET Clinics 2022. [DOI: 10.1016/j.cpet.2021.12.001] [Reference Citation Analysis]
17 Grimm M, Hoefert S, Krimmel M, Biegner T, Feyen O, Teriete P, Reinert S. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies. Oral Maxillofac Surg 2016;20:295-302. [PMID: 26875085 DOI: 10.1007/s10006-016-0549-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
18 Nair V, Auger S, Kochanny S, Howard FM, Ginat D, Pasternak-Wise O, Juloori A, Koshy M, Izumchenko E, Agrawal N, Rosenberg A, Vokes EE, Skandari MR, Pearson AT. Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal Carcinoma. JAMA Netw Open 2022;5:e227240. [PMID: 35416988 DOI: 10.1001/jamanetworkopen.2022.7240] [Reference Citation Analysis]
19 Roman BR, Goldenberg D, Givi B; The Education Committee of American Head and Neck Society (AHNS). AHNS Series-Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors: AHNS Series-NCCN guidelines for follow-up and surveillance. Head Neck 2016;38:168-74. [DOI: 10.1002/hed.24100] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
20 Pedemonte G, Esteller E, Villatoro JC, Costa JM, Valero C, Quer M, León X. Elective neck dissection during salvage surgery after radiotherapy in patients with head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital 2018;38:86-93. [PMID: 29967555 DOI: 10.14639/0392-100X-1378] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Sheikhbahaei S, Ahn SJ, Moriarty E, Kang H, Fakhry C, Subramaniam RM. Intratherapy or Posttherapy FDG PET or FDG PET/CT for Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis of Prognostic Studies. American Journal of Roentgenology 2015;205:1102-13. [DOI: 10.2214/ajr.15.14647] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
22 Bird T, Barrington S, Thavaraj S, Jeannon J, Lyons A, Oakley R, Simo R, Lei M, Guerrero Urbano T. 18F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma. Eur J Nucl Med Mol Imaging 2016;43:1239-47. [DOI: 10.1007/s00259-015-3290-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
23 Agrawal A, Prakash A, Choudhury S, Manikandan MV, Jain Y, Purandare N, Puranik A, Shah S, Rangarajan V. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Postsurgical Setting in Head and Neck Cancers - A Pictorial Essay. Indian J Nucl Med 2021;36:195-200. [PMID: 34385794 DOI: 10.4103/ijnm.ijnm_204_20] [Reference Citation Analysis]
24 Galiza Barbosa F, Riesterer O, Tanadini‐lang S, Stieb S, Studer G, Pruschy M, Huber GF, Huellner MW, Stolzmann P, Veit‐haibach P. Evaluation of 18F‐FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma. Head & Neck 2019;42:163-70. [DOI: 10.1002/hed.25975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
25 Abdel Razek AAK. Arterial spin labelling and diffusion-weighted magnetic resonance imaging in differentiation of recurrent head and neck cancer from post-radiation changes. J Laryngol Otol 2018;132:923-8. [DOI: 10.1017/s0022215118001743] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
26 Garg G, Benchekroun MT, Abraham T. FDG-PET/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls. Semin Nucl Med 2017;47:579-94. [PMID: 28969758 DOI: 10.1053/j.semnuclmed.2017.07.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
27 Decazes P, Thureau S, Modzelewski R, Damilleville-Martin M, Bohn P, Vera P. Benefits of positron emission tomography scans for the evaluation of radiotherapy. Cancer Radiother 2020;24:388-97. [PMID: 32448741 DOI: 10.1016/j.canrad.2020.02.007] [Reference Citation Analysis]
28 Sahu A, Nandakumar N, Sawant S, Krishna CM. Recurrence prediction in oral cancers: a serum Raman spectroscopy study. Analyst 2015;140:2294-301. [PMID: 25619332 DOI: 10.1039/c4an01860e] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
29 Workman AD, Velasquez N, Khan NI, Borchard NA, Kuan EC, Palmer JN, Wang EW, Patel ZM, Adappa ND. Rates of symptomatology are lower in recurrent sinonasal malignancy than in other recurrent cancers of the head and neck: a multi‐institutional study. Int Forum Allergy Rhinol 2019;9:688-94. [DOI: 10.1002/alr.22310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Abu-Ghanem S, Yafit D, Ghanayem M, Abergel A, Yehuda M, Fliss DM. Utility of first positron emission tomography-computed tomography scan as a prognostic tool following treatment of sinonasal and skull base malignancies. Head Neck 2019;41:701-6. [PMID: 30521131 DOI: 10.1002/hed.25416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
31 Kitajima K, Suenaga Y, Sugimura K. Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma. Jpn J Radiol 2015;33:776-89. [DOI: 10.1007/s11604-015-0495-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Cheung MK, Ong SY, Goyal U, Wertheim BC, Hsu CC, Yi SK. False Positive Positron Emission Tomography / Computed Tomography Scans in Treated Head and Neck Cancers. Cureus 2017;9:e1146. [PMID: 28497009 DOI: 10.7759/cureus.1146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
33 Lin HC, Kang CJ, Huang SF, Wang HM, Lin CY, Lee LY, Liao CT, Yen TC. Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging 2017;44:1702-11. [PMID: 28547178 DOI: 10.1007/s00259-017-3713-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
34 Mat Lazim N, Elliott M, Wykes J, Clark J. Oligometastases in head and neck carcinoma and their impact on management. ANZ J Surg 2021. [PMID: 33634950 DOI: 10.1111/ans.16622] [Reference Citation Analysis]
35 Workman AD, Glicksman JT, Parasher AK, Carey RM, Brooks SG, Kennedy DW, Nabavizadeh SA, Learned KO, Palmer JN, Adappa ND. 18FDG PET/CT in Routine Surveillance of Asymptomatic Patients following Treatment of Sinonasal Neoplasms. Otolaryngol Head Neck Surg 2017;157:1068-74. [PMID: 28809123 DOI: 10.1177/0194599817722959] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
36 Rohde M, Nielsen AL, Johansen J, Sørensen JA, Diaz A, Pareek M, Asmussen JT, Gerke O, Thomassen A, Gyldenkerne N, Døssing H, Bjørndal K, Høilund-Carlsen PF, Godballe C. Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma. Oral Oncol 2019;94:1-7. [PMID: 31178202 DOI: 10.1016/j.oraloncology.2019.04.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Strauss SB, Aiken AH, Lantos JE, Phillips CD. Best Practices: Application of NI-RADS for Posttreatment Surveillance Imaging of Head and Neck Cancer. AJR Am J Roentgenol 2021;216:1438-51. [PMID: 32876470 DOI: 10.2214/AJR.20.23841] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Peltenburg B, Driessen JP, Philippens MEP, Pameijer FA, Castelijns J, Dankbaar JW, Dorgelo B, Lange CAH, Meijer FJA, Palm WM, Roosendaal SD, Steens SCA, Verbist BM, Stegeman I, Janssen LM, de Bree R, Terhaard CHJ. The interobserver agreement in the detection of recurrent HNSCC using MRI including diffusion weighted MRI. Eur J Radiol 2018;105:134-40. [PMID: 30017269 DOI: 10.1016/j.ejrad.2018.05.031] [Reference Citation Analysis]